A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 298
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CpG-ODN
Long Form : CpG oligodeoxynucleotides
No. Year Title Co-occurring Abbreviation
2022 A candidate vaccine composed of live nonpathogenic Iranian Lizard Leishmania mixed with Chitin microparticles protects mice against Leishmania major infection. CMPs, ILL
2021 Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages. IL-37, NF-kappaB, siRNA, TLR9, TNF-alpha
2021 An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production. AIT, DC, MPLA, OVA, PBMC, TLR4
2021 Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy. DCs, TLR9
2021 CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance. AIT
2021 HCV Core/NS3 Protein Immunization with "N-Terminal Heat Shock gp96 Protein (rNT (gp96))" Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice. HCV, IgG
2021 Heterologous administration of HPV16 E7 epitope-loaded nanocomplexes inhibits tumor growth in mouse model. Ad, APCs
2021 Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice. LNPs, VZV-gE
2021 Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia. CNS, IMQ, LPS
10  2021 Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy. aPD-L1, Ce6, immuno-SDT, SDT, US
11  2021 Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy. AIT, DNA, mRNA, Treg
12  2021 Phosphate-modif ied CpG oligonucleotides induce in vitro maturation of human myeloid dendritic cells. DCs, IL-4
13  2021 Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses. TRMs
14  2021 Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide. PD
15  2021 The relationship between the efficacy of talazoparib and the functional toll-like receptors 3 and 9 in triple negative breast cancer. IRF7, TAL, TLRs, TNBC, WST-1
16  2021 [CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model: immunohistochemical evaluation of the local response to immunostimulatory DNA]. ICAM-1, UCC
17  2020 Ameliorating effect of CpG-ODN (oligodeoxynucleotide) against radiation-induced lung injury in mice. CT, K-CpG, NO, PC, RILI, ROS
18  2020 Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses. APCs, OVA, PAMPs, PRRs, RIG-I
19  2020 Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice. ---
20  2020 Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice. CMI, ELISPOT, IFN-gamma, IL-2, PLGA, VZV-gE
21  2020 Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. Chol, CTL, DOTAP, HPV, SPC, TME
22  2020 N-Acetyl-l-Leucine-Polyethyleneimine-Mediated Delivery of CpG Oligodeoxynucleotides 2006 Inhibits RAW264.7 Cell Osteoclastogenesis. MMP-9, N-Ac-L-Leu-PEI, RANK
23  2020 Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice. FLUX, KCs, TLR9, WT
24  2020 The Innate Immune Response to Infection Induces Erythropoietin-Dependent Replenishment of the Dendritic Cell Compartment. DC, EPO, TLR9
25  2020 The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma. MPLA, ROS
26  2020 [Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic Leukemia]. CC, CLL, I-FISH, PHA
27  2020 [CpG ODN synergistically promotes proliferation and migration of mouse RAW264.7 macrophages induced by lipopolysaccharide]. ERK, JNK, LPS, p38 MAPK
28  2019 Anti-Tumor Activity of Mannose-CpG-Oligodeoxynucleotides-Conjugated and Hepatoma Lysate-Loaded Nanoliposomes for Targeting Dendritic Cells In Vivo. DC
29  2019 Circulating CD24hiCD38hi regulatory B cells correlate inversely with the ThEM17 cell frequency in granulomatosis with polyangiitis patients. GPA, HCs, PMA, SEB, ThEM17
30  2019 Decellularized Lymph Node Scaffolding as a Carrier for Dendritic Cells to Induce Anti-Tumor Immunity. BMDCs, DCs, dLN, ECM, IL, MHC, OVA
31  2019 ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line. 4NQO, EMT, ERK, OSCC
32  2019 Highly efficient cascading synergy of cancer photo-immunotherapy enabled by engineered graphene quantum dots/photosensitizer/CpG oligonucleotides hybrid nanotheranostics. GQD, TLR9
33  2019 Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy. AAV, CTSK, IF, IHC, Pg, qRT-PCR, RA, siRNA, TLR9
34  2019 Liposomal and CpG-ODN formulation elicits strong humoral immune responses to recombinant Staphylococcus aureus antigens in heifer calves. ClfA, FnBPA, LIP
35  2019 Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome. BALF
36  2019 Natural and inducible regulatory B cells are widely distributed in ovine lymphoid tissues. JPP, LN
37  2019 Recombinant plasmids containing CpG with porcine host defense peptides (PR-39/pBD-1) modulates the innate and adaptive intestinal immune responses (including maternal-derived) in piglets. ETEC, HDPs
38  2019 [Study of local application of CpG-oligodeoxynucleotide combined with 4-1BB monoclonal antibody to treat hepatoma- bearing mice]. IFN, IL
39  2018 Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV). OPV, sIPV
40  2018 Comparative evaluation of cell- and serum-derived exosomes to deliver immune stimulators to lymph nodes. bo-EXO, Exos, MPLA, SCS
41  2018 Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors. ---
42  2018 Evaluation of the TLR negative regulatory network in CVID patients. CVID, LPS, PBMCs, PID
43  2018 Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection. ---
44  2018 Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers. NO, TAMs
45  2017 Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic epithelium. LPS, TLRs
46  2017 Cloning and expression analysis of a Toll-like receptor 21 (TLR21) gene from turbot, Scophthalmus maximus. LRR, qPCR, TIR, TLR21, TM, TRBIV
47  2017 CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis. LV, LVFS, MI, TLR9
48  2017 CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor alpha based DNA vaccine. FRalpha
49  2017 CpG-ODN Stimulation in Population Screening Monoclonal B-Cell Lymphocytosis. CBA, FISH, LyB, MBL, sMBL
50  2017 Effects of inhibitors of transcription factors, nuclear factor-kappaB and activator protein 1, on the expression of proinflammatory cytokines and chemokines induced by stimulation with Toll-like receptor ligands in hen vaginal cells. AP-1, LPS, NF-kappaB, TLR
51  2017 In vitro effects of the toll-like receptor agonists monophosphoryl lipid A and CpG-rich oligonucleotides on cytokine production by equine cells. AIT, IBH, IFN, IL, MPLA, PBMCs, Th2, TLR
52  2017 Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis. IPF, NOD, OTU1341, PFS, TLR9
53  2017 Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. CLL, IBR, MCL, VEN
54  2017 TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency. CVID, RA
55  2017 [Effects of adipose-derived stem cells and non-methylated CpG-oligodeoxynucleotides on peripheral blood CD4+CD25+ regulatory T cells in young mice with food allergy]. ADSC, OVA, Treg
56  2016 A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. ART, ELISA, IFN-alpha, PBMCs, TLR
57  2016 Changes in apoptosis-related gene expression and cytokine release in breast cancer cells treated with CpG-loaded magnetic PAMAM nanoparticles. DcMNPs
58  2016 CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via Induction of IFN-gamma⁺ Th1 Cells or Foxp3⁺ Regulatory T Cells in the Lung. ---
59  2016 CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts. DMPM
60  2016 FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia. CLL, FISH, NGS
61  2016 High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-kappaB signaling pathway in non-small cell lung cancer cells. IR, NF-kappaB, NSCLC, PD-L1, TLR9
62  2016 Immune response to recombinant Leishmania infantum lipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB/c mice. rLPG3
63  2016 Impaired toll like receptor 9 response in pulmonary tuberculosis. IL-8, LPS, PBMC, TB, TLR
64  2016 Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4. IRA, KO, LPS, MZ, TLR, WT
65  2016 Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen. ---
66  2016 Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides. LPS, SP, TLR
67  2016 The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to radiation-induced lung fibrosis in mice. CTL, RILF, RT
68  2016 Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning. ACT, MPL, TBI, TLR
69  2016 Transcriptomic Insights into the Response of Placenta and Decidua Basalis to the CpG Oligodeoxynucleotide Stimulation in Non-Obese Diabetic Mice and Wild-Type Controls. DEGs, NOD, PPAR, WT
70  2016 [Regulatory B cells activated by CpG-ODN combined with anti-CD40 monoclonal antibody inhibit CD4(+)T cell proliferation]. IFN-gamma, IL-10
71  2015 A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderly. ---
72  2015 Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration. MPLA, TLR, WIV
73  2015 CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells. Oct-4, SER
74  2015 CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection. ---
75  2015 CpG-Oligodeoxynucleotides in Chronic Rhinosinusitis Cell Culture. CRS, IL-5, MMP-9, TLR9
76  2015 Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility. CI, HLA, KD, KIR, OR
77  2015 Immune complex negatively regulates Toll-like receptor 9-mediated immune responses in B cells through the inhibitory Fc-gamma receptor IIb. IC, TLR9
78  2015 Mannan-binding lectin reduces CpG DNA-induced inflammatory cytokine production by human monocytes. MBL
79  2015 Molecular cloning and expression studies of the adapter molecule myeloid differentiation factor 88 (MyD88) in turbot (Scophthalmus maximus). IL-1R, LPS, MyD88, NF-kappaB, TIR, TLR, TRBIV
80  2015 Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long‑lasting and balanced immune responses. HBsAg, IDR, Th
81  2015 [Effect of jiedu quyu zishen recipe on TLR9 signal pathway of murine macrophage cells]. JQZR, MyD88, SLE, TLR9
82  2014 Comprehensive comparative and semiquantitative proteome of a very low number of native and matched epstein-barr-virus-transformed B lymphocytes infiltrating human melanoma. EBV, TIBCs
83  2014 CpG-oligodeoxynucleotides suppress the proliferation of A549 lung adenocarcinoma cells via toll-like receptor 9 signaling and upregulation of Runt-related transcription factor 3 expression. TLR9
84  2014 Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses. TLR9
85  2014 Functional expression of TLR9 in esophageal cancer. COX-2, CQ, EC, MMP, TLR9
86  2014 MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration. miRNAs, PI3K, TCN, TLR9, WM
87  2014 Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein. alpha-GalCer
88  2014 Phagocytosis of bafilomycin A1-treated apoptotic neuroblastoma cells by bone marrow-derived dendritic cells initiates a CD8alpha+ lymphocyte response to neuroblastoma. BafA1, BMDCs, IFN-gamma, LPS, TLR9
89  2014 Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9. HCC, TLRs
90  2014 Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model. IPC, PI3K, TLR, TTC
91  2014 Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants. HI, QS
92  2014 The stimulatory effect of different CpG oligonucleotides on the maturation of chicken bone marrow-derived dendritic cells. BMDC, CD, DC, GM-CSF
93  2014 TLR-9 agonist immunostimulatory sequence adjuvants linked to cancer antigens. CTL, TLR9
94  2014 [Comparison of the chemoimmunotherapeutic effect of doxorubicin and bafilomycin-A1 in mouse neuroblastoma cells]. BafA1, BMDCs, IFN-g, TLR
95  2013 Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells. DCs, NG, pDCs, TLR
96  2013 Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. tBreg
97  2013 Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases. ---
98  2013 Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken. AIV, TLR
99  2013 CpG oligodeoxynucleotide induces bone marrow precursor cells into myeloid-derived suppressor cells. BM, DCs, GM-CSF, MDSCs
100  2013 CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin. 5-FU